Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 

EPAX Launches New 'ECOVISION' Web Site

Read press release

 
 

EPAX AS Achieves ‘Friend of the Sea’ Certification

Leading omega-3 supplier EPAX AS was awarded Friend of the Sea (FOS) certification for its sustainable marine sourcing and production methods.

 

Read press release, English and Norwegian versions.

 

 

 
 

Earthquake in Chile

The Austevoll Seafood group has many activities and employees in Chile. The group has its land based activities in the area south of the epicentre of the earthquake, in the town of Coronel.

Read press release


 
 

EPAX AS Completes New Eco-friendly HQ Construction

Read Norwegian or English press release

 

 
 

EPAX AS expands North American presence

hires André Markussen as Sales Manager.

 

Read press release

 

 
 

EPAX Receives Banner Award

Read press release

 
 

Epax' crude fish oil supplier, the Austral Group, complies with new EU food regulations.

Read press release  

 

 

 
 

EPAX sister company Austral Group wins National Peruvian Award

Read Norwegian or English press release

 

 

 
 

Press Release Oct. 16 2008

EPAX AS receives Frost & Sullivan 2008 European Omega-3 ingredients excellence in product quality award

 
 

Press Release 27 June 2008

EPAX AS recognised as a 2007 top supplier by Banner Pharmacaps, INC.

 
 

Purity Beyond Measure

EPAX' American launch of expanded purity concept a success
 

Omega-3 Study Recognized

National Institutes of Health recognizes Alzheimer study
 

NBJ Award

EPAX garners scientific award for Alzheimer study using EPAX 1050 TG Omega-3
 
EPAX News & Events

Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map        Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com